| This week's sponsor is TD2. | | | |
Featured Story | | | Wednesday, September 27, 2017 Rubius Therapeutics has lured Chris Carpenter, M.D., Ph.D., away from GlaxoSmithKline to serve as its CMO. Carpenter will work as point person on Rubius’ clinical development activities as it gears up to move the first of its CAR-T-rivaling cell therapies into human testing. |
|
|
| This week's sponsor is FierceBiotech. | | | FierceBiotech Executive Summit- London
Join FierceBiotech for our third annual Executive Summit in London. We'll gather the experts together to discuss innovation around R&D in the UK and look ahead to what's in store for 2018 with leaders in the field discussing trends in the industry. |
Top Stories Wednesday, September 27, 2017 The European Medicines Agency has warned its Brexit-driven relocation could permanently damage the region’s regulatory system. EMA sounded the alarm after a staff survey found as few as 6% of its staff would move to some of the 19 cities vying to host the agency when it leaves London. Wednesday, September 27, 2017 Micro cap biotech Mateon will immediately end a cancer combo with Roche’s aging Avastin in ovarian cancer as poor results from a phase 2/3 trial influence a shift in focus away from its once-leading medication. Monday, September 25, 2017 RBM shouldn’t be a point of concern, but rather a point of validation of what matters. It’s, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site-and patient-centric environment. Wednesday, September 27, 2017 U.K. biotech NeRRe Therapeutics has decided to streamline its R&D portfolio by setting up a brand-new company focusing on women’s health. Wednesday, September 27, 2017 Treos Bio’s lead cancer vaccine program, aimed to treat metastatic colorectal cancer, is slated to hit the clinic soon, and it has tapped PPD to manage the study. Tuesday, September 26, 2017 The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. This year’s crop comprises some of the best-funded startups we’ve seen and speaks volumes about the rude health of early-stage biomedical research. Wednesday, September 27, 2017 Apple, Johnson & Johnson and a clutch of other big-name tech and device companies have joined an FDA program to fast-track digital health apps. The pilot program will offer precertified companies an abbreviated regulatory path to market, freeing them from the lengthy cycle times faced by apps classed as medical devices today. | This week's sponsor is CMed. | | | |
Resources Sponsored by: Veeva Systems The 2017 Unified Clinical Operations Survey finds that 99% of respondents report the need to unify their clinical applications, including CTMS, EDC, eTMF, and study start-up. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Life Sciences Innovation Awards | Don't Miss This Opportunity Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 